Thrombotic complications during induction chemotherapy of acute childhood lymphoblastic leukemia

Journal of the Medical Association of Thailand

Volumn 85, Issue SUPPL. 2, 2002, Pages

  Kankirawatana, Suthida ^a   Sanpakit, Kleebsabai ^a   Akkabutr, Patraporn ^a   Mahasandana, Chularatana ^a   Veerakul, Gavivann ^a   Tanphaichitr, Voravarn S ^a   Suwantol, Lerlugsn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Acute Childhood Lymphoblastic Leukemia; Induction Chemotherapy; Thrombosis

Indexed keywords

ANTITHROMBIN; ASPARAGINASE; BLOOD CLOTTING FACTOR; COUMARIN; DEXAMETHASONE; DOXORUBICIN; FIBRINOGEN; FRESH FROZEN PLASMA; HEPARIN; METHOTREXATE; PHENYTOIN; PREDNISONE; PROTEIN C; PROTEIN S; TAMOXIFEN; VINCRISTINE;

ANTICOAGULATION; ARTICLE; BRAIN INFARCTION; CANCER CHEMOTHERAPY; CHILD; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; FEMALE; HUMAN; INCIDENCE; INFANT; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PROSPECTIVE STUDY; PROTHROMBIN TIME; SUPERIOR CAVA VEIN OBSTRUCTION; THROMBIN TIME; THROMBOSIS;

AGE DISTRIBUTION; ANTICOAGULANTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; THAILAND; THROMBOSIS;

EID: 0036702891     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Luzzatto G, Schafer AI. The Prethrombotic state in cancer. Seminars in Oncol 1990; 17: 147-59.
2. Lee AY, Lovine MN. The thrombophilic state induced by therapeutic agents in the cancer patient. Semin Thromb Hemost 1999; 25: 137-45.
3. Ramsay NK, Coccia PF, Kravit W, Nesbit ME, Edson JR. The effect of L-asparaginase on plasma coagulation factors in acute lymphoblastic leukemia. Cancer 1977; 40: 1398-401.
4. Alberts SR, Bretscher M, Wiltsic SC, O'Neill BP, Moleri B, Witzig TE. Thrombosis related to the use of L-asparaginase in adult with acute lymphobastic leukemia : A need to consider coagulation monitoring and clotting factor replacement. Leuk Lymphoma 1999; 32: 489-96.
5. Sutor AH, Mall V, Thomas KB. Bleeding and Thrombosis in children with acute lymphoblastic leukemia, treated according to the ALL-BFM-90 Protocol. Klin Padiatr 1999; 211: 201-4.
6. Mauz-Karholz C, Junker R, Gobel U, Nowak-Gotte U. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E Coli asparaginase (COALL-92 and 97 protocols). Thromb Haemost 2000; 83: 840-3.
7. Soong BF, Miller SP. Coagulation disorders in Cancer III fibrinolysis and Inhibitors. Cancer 1970; 25: 867-74.
8. Doll DC, Ringenberh QS, Yarbro JW. Vascular toxicity associated with antineoplastic drugs. J Clin Oncol 1980; 4: 1405-17.
9. Priest JR, Ramsay NK, Steinherz PG, et al. A syndrome of thrombosis and hemorrhage complicatiry L-asparaginase therapy for childhood acute lymphoblastic leukemia. J Pediatr 1982; 100: 984-9.
10. Feinberg WM, Swenson MR. Cerebsovascular complications of L-asparaginase Therapy. Neurology 1988; 38: 127-33.
11. Pui HC, Jackson CW, Chesney CM, et al. Involvement of von Willebrand factor in thrombosis following asparaginase-prednisone-vincristine therapy for leukemia. Am J Hematol 1987; 25: 291-8.
12. Millot F, Traore P, Boinot C, et al. Homonymous lateral hemianopsia revealing cerebral thrombophlebitis. Role of a deficiency of protein S. induced by L-asparaginase. Presse Med 2001; 30: 855-7.
13. Lee JH, Kim SW, Sung Kim J. Sagittal sinus thrombosis associated with transient free protein S deficiency after L-asparaginase treatment: Case report and review of the literature. Clin Neurosurgery 2000; 102: 33-6.
14. Elhasid R, Lanir N, Sharon R, et al. Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia. Blood Coag Fibrinol 2001; 12: 367-70.
15. Bick RL. Clinical relevance of antithrombin III. Semin Thromb Hemost 1982; 8: 276-80.